“Axillary Hyperhidrosis HDSM-Ax-7 Patient-Reported Outcomes for Sofpironium Topical Gel,12.45%: A Multicenter, Randomized, Controlled Double-Blind Study (NCT03836287)” (2025) SKIN The Journal of Cutaneous Medicine, 9(4), p. s588. doi:10.25251/yvdyat28.